Inhibrx, Inc. (INBX)
NASDAQ: INBX · IEX Real-Time Price · USD
34.70
+0.21 (0.61%)
At close: May 17, 2024, 4:00 PM
34.54
-0.16 (-0.46%)
After-hours: May 17, 2024, 5:15 PM EDT
Inhibrx Employees
Inhibrx had 172 employees on December 31, 2023. The number of employees increased by 31 or 21.99% compared to the previous year.
Employees
172
Change (1Y)
31
Growth (1Y)
21.99%
Revenue / Employee
$10,366
Profits / Employee
-$1,576,483
Market Cap
1.82B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 172 | 31 | 21.99% |
Dec 31, 2022 | 141 | 29 | 25.89% |
Dec 31, 2021 | 112 | 21 | 23.08% |
Dec 31, 2020 | 91 | 11 | 13.75% |
Dec 31, 2019 | 80 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
Addus HomeCare | 34,846 |
Ginkgo Bioworks Holdings | 1,218 |
Veracyte | 815 |
LeMaitre Vascular | 630 |
Ardelyx | 267 |
Syndax Pharmaceuticals | 184 |
Kura Oncology | 142 |
Protagonist Therapeutics | 112 |
INBX News
- 8 days ago - Inhibrx, Inc. Announces Updated When-Issued Trading Date for Anticipated Spin-Off - PRNewsWire
- 9 days ago - INHIBRX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Inhibrx, Inc. - INBX - Business Wire
- 10 days ago - Inhibrx, Inc. Announces Record Date and Expected Distribution Time for Anticipated Spin-Off and the Expected Merger Effective Time for Anticipated Merger - PRNewsWire
- 2 months ago - Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial Results - PRNewsWire
- 4 months ago - Unitholder Alert: Ademi LLP investigates whether Inhibrx, Inc. has obtained a Fair Price in its transaction with Sanofi - PRNewsWire
- 4 months ago - Sanofi To Acquire Inhibrx in $1.7 Billion Deal To Boost Rare Disease Drugs Pipeline - Investopedia
- 4 months ago - INBX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Inhibrx, Inc. Is Fair to Shareholders - Business Wire
- 4 months ago - Sanofi to Buy Rare-Disease Assets From Inhibrx - WSJ